{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T07:44:35Z","timestamp":1794037475233,"version":"4.8.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T00:00:00Z","timestamp":1677110400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Methods & Clinical Development"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.omtm.2023.02.012","type":"journal-article","created":{"date-parts":[[2023,2,26]],"date-time":"2023-02-26T17:39:44Z","timestamp":1677433184000},"page":"120-132","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Targeted adenovirus-mediated transduction of human T\u00a0cells in\u00a0vitro and in\u00a0vivo"],"prefix":"10.1016","volume":"29","author":[{"given":"Patrick C.","family":"Freitag","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meike","family":"Kaulfuss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lea","family":"Fl\u00fchler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliane","family":"Mietz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik","family":"Br\u00fccher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Kolibius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. Patricia","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheena N.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"M\u00fcnz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Obinna","family":"Chijioke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Pl\u00fcckthun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2023.02.012_bib1","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.cell.2017.01.016","article-title":"The principles of engineering immune cells to treat cancer","volume":"168","author":"Lim","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.omtm.2023.02.012_bib2","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/s41586-018-0326-5","article-title":"Reprogramming human T\u00a0cell function and specificity with non-viral genome targeting","volume":"559","author":"Roth","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.omtm.2023.02.012_bib3","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/s41592-019-0329-7","article-title":"One-step generation of modular CAR-T cells with AAV\u2013Cpf1","volume":"16","author":"Dai","year":"2019","journal-title":"Nat. Methods"},{"key":"10.1016\/j.omtm.2023.02.012_bib4","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1126\/science.aaa4967","article-title":"Adoptive cell transfer as personalized immunotherapy for human cancer","volume":"348","author":"Rosenberg","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.omtm.2023.02.012_bib5","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.ymthe.2020.10.022","article-title":"Clinical perspective: treatment of aggressive B cell lymphomas with FDA-approved CAR-T cell therapies","volume":"29","author":"Leick","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2023.02.012_bib6","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.omtm.2016.12.006","article-title":"Global manufacturing of CAR T\u00a0cell therapy","volume":"4","author":"Levine","year":"2017","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2023.02.012_bib7","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nm.4313","article-title":"Refining strategies to translate genome editing to the clinic","volume":"23","author":"Cornu","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtm.2023.02.012_bib8","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ymthe.2005.07.688","article-title":"High-efficiency transfection of primary human and mouse T lymphocytes using RNA electroporation","volume":"13","author":"Zhao","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2023.02.012_bib9","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1126\/science.abm0594","article-title":"CAR T\u00a0cells produced in\u00a0vivo to treat cardiac injury","volume":"375","author":"Rurik","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.omtm.2023.02.012_bib10","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s12943-019-1057-4","article-title":"Next generation chimeric antigen receptor T\u00a0cells: safety strategies to overcome toxicity","volume":"18","author":"Yu","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.omtm.2023.02.012_bib11","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1002\/1873-3468.13731","article-title":"Retargeting adenoviruses for therapeutic applications and vaccines","volume":"594","author":"Barry","year":"2020","journal-title":"FEBS Lett."},{"key":"10.1016\/j.omtm.2023.02.012_bib12","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1007\/s11262-017-1471-x","article-title":"Gene therapy with helper-dependent adenoviral vectors: lessons from studies in large animal models","volume":"53","author":"Brunetti-Pierri","year":"2017","journal-title":"Virus Gene."},{"key":"10.1016\/j.omtm.2023.02.012_bib13","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13045-020-00922-1","article-title":"Oncolytic viruses for cancer immunotherapy","volume":"13","author":"Hemminki","year":"2020","journal-title":"J.\u00a0Hematol. Oncol."},{"key":"10.1016\/j.omtm.2023.02.012_bib14","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1634\/theoncologist.7-1-46","article-title":"Adenoviral gene therapy","volume":"7","author":"Vorburger","year":"2002","journal-title":"Oncol."},{"key":"10.1016\/j.omtm.2023.02.012_bib15","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.omtm.2021.01.002","article-title":"iMATCH: an integrated modular assembly system for therapeutic combination high-capacity adenovirus gene therapy","volume":"20","author":"Br\u00fccher","year":"2021","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2023.02.012_bib16","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.omtm.2020.01.014","article-title":"A single, All-in-one helper-dependent adenovirus to deliver donor DNA and CRISPR\/Cas9 for efficient homology-directed repair","volume":"17","author":"Palmer","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2023.02.012_bib17","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1146\/annurev-virology-092818-015550","article-title":"Adenovirus entry: from infection to immunity","volume":"6","author":"Greber","year":"2019","journal-title":"Annu. Rev. Virol."},{"key":"10.1016\/j.omtm.2023.02.012_bib18","doi-asserted-by":"crossref","first-page":"4695","DOI":"10.1242\/jcs.00876","article-title":"T-cell integrins: more than just sticking points","volume":"116","author":"Hogg","year":"2003","journal-title":"J.\u00a0Cell Sci."},{"key":"10.1016\/j.omtm.2023.02.012_bib19","doi-asserted-by":"crossref","first-page":"485","DOI":"10.3390\/ijms19020485","article-title":"Integrins in T\u00a0cell physiology","volume":"19","author":"Bertoni","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omtm.2023.02.012_bib20","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1128\/jvi.69.4.2257-2263.1995","article-title":"Upregulation of integrins alpha v beta 3 and alpha v beta 5 on human monocytes and T lymphocytes facilitates adenovirus-mediated gene delivery","volume":"69","author":"Huang","year":"1995","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2023.02.012_bib21","doi-asserted-by":"crossref","first-page":"e0169532","DOI":"10.1371\/journal.pone.0169532","article-title":"Cell-surface integrins and CAR are both essential for adenovirus type 5 transduction of canine cells of lymphocytic origin","volume":"12","author":"Agarwal","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.omtm.2023.02.012_bib22","doi-asserted-by":"crossref","first-page":"13159","DOI":"10.1073\/pnas.95.22.13159","article-title":"Adenoviral-mediated gene transfer in lymphocytes","volume":"95","author":"Leon","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2023.02.012_bib23","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.exphem.2004.03.010","article-title":"Gene transfer into human T lymphocytes and natural killer cells by Ad5\/F35 chimeric adenoviral vectors","volume":"32","author":"Schroers","year":"2004","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.omtm.2023.02.012_bib24","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S1357-2725(99)00092-8","article-title":"Human membrane cofactor protein (MCP, CD46): multiple isoforms and functions","volume":"31","author":"Seya","year":"1999","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.omtm.2023.02.012_bib25","doi-asserted-by":"crossref","first-page":"e54952","DOI":"10.1371\/journal.pone.0054952","article-title":"Adenovirus serotype 5 vectors with Tat-PTD modified hexon and serotype 35 fiber show greatly enhanced transduction capacity of primary cell cultures","volume":"8","author":"Yu","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.omtm.2023.02.012_bib26","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.jmb.2010.10.040","article-title":"Her2-specific multivalent adapters confer designed tropism to adenovirus for gene targeting","volume":"405","author":"Dreier","year":"2011","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.omtm.2023.02.012_bib27","doi-asserted-by":"crossref","first-page":"E869","DOI":"10.1073\/pnas.1213653110","article-title":"Development of a generic adenovirus delivery system based on structure-guided design of bispecific trimeric DARPin adapters","volume":"110","author":"Dreier","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2023.02.012_bib28","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1021\/acs.bioconjchem.2c00346","article-title":"Modular adapters utilizing binders of different molecular types expand cell-targeting options for adenovirus gene delivery","volume":"33","author":"Freitag","year":"2022","journal-title":"Bioconjugate Chem."},{"key":"10.1016\/j.omtm.2023.02.012_bib29","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/s41467-017-02707-6","article-title":"Adenoviral vector with shield and adapter increases tumor specificity and escapes liver and immune control","volume":"9","author":"Schmid","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtm.2023.02.012_bib30","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2017925118","article-title":"SHREAD gene therapy platform for paracrine delivery improves tumor localization and intratumoral effects of a clinical antibody","volume":"118","author":"Smith","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2023.02.012_bib31","doi-asserted-by":"crossref","first-page":"eabm9043","DOI":"10.1126\/scitranslmed.abm9043","article-title":"NK cells with tissue-resident traits shape response to immunotherapy by inducing adaptive antitumor immunity","volume":"14","author":"Kirchhammer","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omtm.2023.02.012_bib32","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/sj.gt.3301488","article-title":"Efficient infection of primitive hematopoietic stem cells by modified adenovirus","volume":"8","author":"Yotnda","year":"2001","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2023.02.012_bib33","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1084\/jem.175.1.217","article-title":"Development of humanized bispecific antibodies reactive with cytotoxic lymphocytes and tumor cells overexpressing the HER2 protooncogene","volume":"175","author":"Shalaby","year":"1992","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.omtm.2023.02.012_bib34","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.4049\/jimmunol.155.4.1903","article-title":"Identification of heavy chain residues in a humanized anti-CD3 antibody important for efficient antigen binding and T\u00a0cell activation","volume":"155","author":"Zhu","year":"1995","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.omtm.2023.02.012_bib35","series-title":"Superagonistic anti-CD28 antibodies. U.S. Patent No. 8,709,414","author":"Hanke","year":"2014"},{"key":"10.1016\/j.omtm.2023.02.012_bib36","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/1479-5876-8-104","article-title":"Comparison of anti-CD3 and anti-CD28-coated beads with soluble anti-CD3 for expanding human T\u00a0cells: differing impact on CD8 T\u00a0cell phenotype and responsiveness to restimulation","volume":"8","author":"Li","year":"2010","journal-title":"J.\u00a0Transl. Med."},{"key":"10.1016\/j.omtm.2023.02.012_bib37","doi-asserted-by":"crossref","first-page":"144","DOI":"10.4049\/jimmunol.164.1.144","article-title":"CD28 costimulation mediates T Cell expansion via IL-2-independent and IL-2-dependent regulation of cell cycle progression","volume":"164","author":"Appleman","year":"2000","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.omtm.2023.02.012_bib38","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0022-2836(03)00896-9","article-title":"Designing repeat proteins: well-expressed, soluble and stable proteins from combinatorial libraries of consensus ankyrin repeat proteins","volume":"332","author":"Binz","year":"2003","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.omtm.2023.02.012_bib39","doi-asserted-by":"crossref","first-page":"4407","DOI":"10.1073\/pnas.91.10.4407","article-title":"Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy","volume":"91","author":"Yang","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2023.02.012_bib40","doi-asserted-by":"crossref","first-page":"8934","DOI":"10.1128\/jvi.70.12.8934-8943.1996","article-title":"Biology of adenovirus vectors with E1 and E4 deletions for liver-directed gene therapy","volume":"70","author":"Gao","year":"1996","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2023.02.012_bib41","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1158\/2326-6066.CIR-14-0200","article-title":"Functional tuning of CARs reveals signaling threshold above which CD8+ CTL antitumor potency is attenuated due to cell Fas-FasL-dependent AICD","volume":"3","author":"K\u00fcnkele","year":"2015","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.omtm.2023.02.012_bib42","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1034\/j.1600-065X.2003.00051.x","article-title":"Activation-induced cell death in T\u00a0cells","volume":"193","author":"Green","year":"2003","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.omtm.2023.02.012_bib43","doi-asserted-by":"crossref","first-page":"e1007039","DOI":"10.1371\/journal.ppat.1007039","article-title":"EBV persistence without its EBNA3A and 3C oncogenes in\u00a0vivo","volume":"14","author":"Murer","year":"2018","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.omtm.2023.02.012_bib44","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1084\/jem.20081720","article-title":"Priming of protective T\u00a0cell responses against virus-induced tumors in mice with human immune system components","volume":"206","author":"Strowig","year":"2009","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.omtm.2023.02.012_bib45","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/gt.2008.10","article-title":"IL4 gene delivery to the CNS recruits regulatory T\u00a0cells and induces clinical recovery in mouse models of multiple sclerosis","volume":"15","author":"Butti","year":"2008","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2023.02.012_bib46","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/gt.2015.64","article-title":"Helper-dependent adenovirus achieve more efficient and persistent liver transgene expression in non-human primates under immunosuppression","volume":"22","author":"Unzu","year":"2015","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2023.02.012_bib47","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.3390\/cancers14112769","article-title":"HydrAd: a helper-dependent adenovirus targeting multiple immune pathways for cancer immunotherapy","volume":"14","author":"Rosewell Shaw","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.omtm.2023.02.012_bib48","series-title":"Biologics License Application (BLA) Clinical Review and Evaluation, STN: 125646\/663 (Tisagenlecleucel)","author":"Upendra","year":"2022"},{"key":"10.1016\/j.omtm.2023.02.012_bib49","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1146\/annurev-immunol-030409-101253","article-title":"On the composition of the preimmune repertoire of T\u00a0cells specific for peptide\u2013major histocompatibility complex ligands","volume":"28","author":"Jenkins","year":"2010","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.omtm.2023.02.012_bib50","doi-asserted-by":"crossref","first-page":"eabl9238","DOI":"10.1126\/scitranslmed.abl9238","article-title":"In\u00a0vivo prime editing of a metabolic liver disease in mice","volume":"14","author":"B\u00f6ck","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omtm.2023.02.012_bib51","doi-asserted-by":"crossref","first-page":"10608","DOI":"10.1128\/JVI.76.21.10608-10616.2002","article-title":"Prevalence and quantitation of species C adenovirus DNA in human mucosal lymphocytes","volume":"76","author":"Garnett","year":"2002","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2023.02.012_bib52","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1128\/JVI.02392-08","article-title":"Latent species C adenoviruses in human tonsil tissues","volume":"83","author":"Garnett","year":"2009","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2023.02.012_bib53","doi-asserted-by":"crossref","first-page":"e63646","DOI":"10.1371\/journal.pone.0063646","article-title":"Presence of adenovirus species C in infiltrating lymphocytes of human sarcoma","volume":"8","author":"Kosulin","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.omtm.2023.02.012_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2015.12.013","article-title":"Persistence and reactivation of human adenoviruses in the gastrointestinal tract","volume":"22","author":"Kosulin","year":"2016","journal-title":"Clin. Microbiol. Infect."}],"container-title":["Molecular Therapy - Methods & Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050123000220?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050123000220?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T13:37:15Z","timestamp":1715953035000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2329050123000220"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":54,"alternative-id":["S2329050123000220"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2023.02.012","relation":{},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeted adenovirus-mediated transduction of human T\u00a0cells in\u00a0vitro and in\u00a0vivo","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2023.02.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s).","name":"copyright","label":"Copyright"}]}}